 |
Amgen is a leading human therapeutics company in the biotechnology industry. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.
www.amgen.com
|
|
 |
Astellas is a global pharmaceutical company based in Japan. Its aim is to contribute to better health for everyone by developing innovative and useful pharmaceuticals and delivering them to patients around the world. www.astellas.com
|
|
 |
Avanir Pharmaceuticals is focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. These products treat central nervous system disorders, inflammation and infectious disease.
www.avanir.com
|
|
 |
Biogen Idec is the third largest biopharmaceutical company in the world, involved with the discovery, development, manufacturing and commercialization of innovative therapies. Its products address diseases such as multiple sclerosis and the multiple challenges of oncology.
www.biogenidec.com
|
|
 |
Biomarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Among the special areas of achievement are treating mucopolysaccharidosis VI (MPS VI) and mucopolysaccharidosis I (MPS I).
www.biomarinpharm.com
|
|
 |
Cephalon is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. www.cephalon.com
|
|
 |
Cubist Pharmaceuticals is a biopharmaceutical company focusing on the research, development and commercialization of pharmaceutical products directed towards the acute care environment.
www.cubist.com
|
|
 |
Eisai Inc. is a wholly-owned subsidiary of Eisai Corporation of North America. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies. Eisai Inc.'s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.
www.eisai.com
|
|
 |
Ipsen is an international specialty pharmaceutical group specializing in targeted therapeutic areas, mainly oncology, endocrinology and neuromuscular disorders. It has R&D centers in Boston, London, Paris and Barcelona.
www.ipsen.com
|
|
 |
Lundbeck Inc. (formerly Ovation Pharmaceuticals, Inc.) is a company located in Deerfield, Illinois, that was established in March 2009 following the acquisition of Ovation Pharmaceuticals, Inc. by H. Lundbeck A/S an international pharmaceutical company specializing in central nervous system (CNS) disorders. With a portfolio of 20 high-need therapies and a pipeline of promising new drugs, Lundbeck is one of the fastest growing pharmaceutical companies in the United States.
www.lundbeckinc.com
|
|
 |
Nycomed is a Danish pharmaceutical company serving hospitals, specialists and general practitioners, as well as OTC medicines in selected markets. Its fields include cardiology, gastroenterology, osteoporosis, respiratory, pain and tissue management.
www.nycomed.com
|
|
 |
Shire is a global specialty biopharmaceutical company serving the specialist physician. It focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. Shire acquired Transkarvotic Therapies Inc (TKT) in 2005 and the new company is called Shire Human Genetic Therapies.
www.shire.com
|
|
 |
Takeda the largest pharmaceutical company in Japan and one of the global leaders of the industry. Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals.
www.takeda.com
|
|
 |
Tercica is a biopharmaceutical company committed to improving endocrine health by partnering with the endocrine community to develop and commercialize new therapeutics for short stature and other metabolic disorders.
www.tercica.com
|
|
 |
The Medicines Company, based in the USA, delivers innovative, cost-effective acute care products in the worldwide hospital marketplace. It markets Angiomax(R) (bivalirudin) for use in patients undergoing coronary angioplasty. www.themedicinescompany.com
|
|
